Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
NCT 06249048 Brief Summary Phase 1/2, Open-label, Multi-center, First-in-human Study of the…
Read more arrow_forwardNCT 06249048 Brief Summary Phase 1/2, Open-label, Multi-center, First-in-human Study of the…
Read more arrow_forwardInside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.